HASH.V stock moved sharply lower intraday on 02 Mar 2026 after Simply Solventless Concentrates (HASH.V) announced a formal restructuring process. The TSX-listed cannabis processor fell to CAD 0.045, a -67.86% intraday change, on volume of 3,170,711 shares versus average volume 337,145. The company said several subsidiaries entered creditor protection under the CCAA, and courts will administer a sale and investment solicitation process. We review valuation, technicals and short-term forecasts and explain what investors should watch next.

HASH.V stock: intraday plunge and the news trigger

The selloff tracked the company filing that three subsidiaries began CCAA restructuring proceedings. The restructuring notice was posted on 27 February 2026 and is cited by Newsfile and Seeking Alpha as the primary catalyst source source. Simply Solventless said operations are expected to continue while the court supervises a sale and investment solicitation process. Today’s drop reflects a rapid reprice of credit and equity risk after the CCAA notice.

HASH.V stock: financial snapshot and valuation metrics

At the intraday quote of CAD 0.045, market capitalization is about CAD 15,015,364 with 115,502,799 shares outstanding. Key ratios show a trailing price-to-earnings near 3.60 and a price-to-book near 0.47. The company reports EPS CAD 0.07, book value per share CAD 0.2765, and a current ratio of 2.53, which supports short-term liquidity. These metrics suggest value-like multiples, but the restructuring raises financing and solvency risk that can invalidate simple valuation comparisons.

HASH.V stock: technicals, intraday levels and liquidity

Technicals show short-term oversold conditions with RSI 38.03 and Williams %R at -100.00, while ADX 19.51 signals no strong trend yet. The day low was CAD 0.035 and the day high CAD 0.06, a wide intraday range that reflects fast-selling pressure. Average volume is 337,145 but today’s 3,170,711 shares show heightened trading and lower liquidity. Watch support at CAD 0.03 and resistance near the 50-day average CAD 0.1413 as reference points for stop and limit orders.

HASH.V stock: Meyka AI rates HASH.V with a score out of 100

Meyka AI rates HASH.V with a score out of 100: 66.72 / 100, Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade balances low valuation multiples against high operational and restructuring risk. Note these grades are model outputs and not financial advice.

HASH.V stock: Meyka AI’s forecast model projects short-term levels

Meyka AI’s forecast model projects a monthly target of CAD 0.100 and a quarterly target of CAD 0.050. Compared with the current price CAD 0.045, the monthly forecast implies an upside of 122.22%, and the quarterly forecast implies an upside of 11.11%. Forecasts are model-based projections and not guarantees. Use these as scenario anchors when sizing positions and planning exits.

HASH.V stock: risks, catalysts and sector context

The primary near-term risk is the CCAA restructuring and potential asset sales that may dilute or change shareholder value. Secondary risks include inventory turnover of 0.99 and long days-of-inventory at 369.83 days, which stress working capital. Catalysts that could stabilise the name include approved DIP financing, a strategic buyer in the Sale Process, or clearer court timelines. Sector-wide, Canadian cannabis names have struggled versus healthcare peers, increasing relative volatility for HASH.V stock.

Final Thoughts

Key takeaways: HASH.V stock plunged to CAD 0.045 intraday on 02 Mar 2026 after Simply Solventless announced CCAA restructuring for major subsidiaries. The balance sheet shows value-style multiples — price-to-book 0.47 and trailing P/E near 3.60 — but the restructuring elevates credit and execution risk. Meyka AI rates HASH.V at 66.72 / 100 (B, HOLD) and models a monthly target of CAD 0.100 and a quarterly target of CAD 0.050, implying immediate upside of 122.22% and 11.11% respectively from the current price. These targets are model projections, not guarantees. Traders should prioritise liquidity and clear court updates. Watch for DIP financing approval, Monitor site postings, and any sale process bids as primary catalysts that could restore price discovery for this TSX-listed cannabis processor. We use Meyka AI as an AI-powered market analysis platform to compile these insights.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.